Skip to main content

Peer Review reports

From: Safety and pharmacokinetics of subcutaneous administration of broadly neutralizing anti-HIV-1 monoclonal antibodies (bNAbs), given to HIV-1 exposed, uninfected neonates and infants: study protocol for a phase I trial

Original Submission
24 Jun 2024 Submitted Original manuscript
2 Jul 2024 Author responded Author comments - Gabriella Scarlatti
Resubmission - Version 2
2 Jul 2024 Submitted Manuscript version 2
Publishing
3 Jul 2024 Editorially accepted
20 Jul 2024 Article published 10.1186/s12879-024-09588-3

You can find further information about peer review here.

Back to article page

BMC Infectious Diseases

ISSN: 1471-2334

Contact us